Masotherapy With Neural Tension in Patients With Parkinson's Disease
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04303338 |
Recruitment Status :
Completed
First Posted : March 11, 2020
Last Update Posted : October 23, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Parkinson Disease | Procedure: Masotherapy with neural tension and masotherapy with non-neural tension | Not Applicable |
In this study the investigators are going to compare the effectiveness of two treatments (masotherapy with neural tension and masotherapy with non-neural tension) in patients with Parkinson disease based on the improved of pain, tremor, functional and life quality.
The investigators are going to divide the number of volunteers in two groups. The first group is going to be treated during 8 weeks with conventional (non-neural tension) masotherapy in the upper limb, the other group is going to be treated with radial neural tension masotherapy during 8 weeks also. To apply the neural tension, the investigators position the patient's upper limb lowering the scapula, elbow extended, internal rotation glenohumeral, forearm pronation, bend and cubital deviation of the wrist, fingers bended and thumb adduction, and finally glenohumeral abduction.
To compare the results between the different groups, the investigators are going to value the patients 4 times, the first one before the beginning of the treatment, the second one and the end of the treatment, the third one after one month completing the treatment, and the last one after three months completing the treatment.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 52 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Investigator) |
Primary Purpose: | Treatment |
Official Title: | Effectiveness of Adding Neural Tension to Masotherapy in Patients With Parkinson's Disease |
Actual Study Start Date : | December 20, 2019 |
Actual Primary Completion Date : | March 16, 2020 |
Actual Study Completion Date : | April 13, 2020 |

Arm | Intervention/treatment |
---|---|
Experimental: Masotherapy with neural tension
The investigators are going to massage the patient´s upper limb applying a radial nerve neural tension. In order to the upper limb should be positioned lowering the scapula, elbow extended, internal rotation glenohumeral, forearm pronation, bend and cubital deviation of the wrist, fingers bended and thumb adduction, and finally glenohumeral abduction.
|
Procedure: Masotherapy with neural tension and masotherapy with non-neural tension
To compare the effectiveness of masotherapy with neural tension and masotherapy with non-neural tension
Other Name: Neurodynamic |
Active Comparator: Masotherapy with non-neural tension
The investigators are going to practice a conventional upper limb massage
|
Procedure: Masotherapy with neural tension and masotherapy with non-neural tension
To compare the effectiveness of masotherapy with neural tension and masotherapy with non-neural tension
Other Name: Neurodynamic |
- Changes in the tremor [ Time Frame: Baseline and 1 month after intervention ]Using the Unified Parkinson's Disease Ratin Scale (UPDRS). Each item is scored 0-4 (0= normal; 10= severe affectation) yielding a total between 0 and 159.
- Changes in the health-related quality of life: Parkinson Disease Quality of Questionnaire (PDQ-39) [ Time Frame: Baseline 8 weeks and 1 month after intervention ]Using the Parkinson Disease Quality of Questionnaire (PDQ-39). Each item is scored 0-4 (0= better life quality; 4= bad life quality) yielding a total between 0 and 156.
- Changes in the strength [ Time Frame: Baseline 8 weeks and 1 month after intervention ]Using the MicroFet 2 Hoggan
- Changes in the manual dexterity [ Time Frame: Baseline 8 weeks and 1 month after intervention ]Using the Coin Rotation Task (CRT)
- Changes in the pain: Visual Analog Scale (VAS) [ Time Frame: Baseline 8 weeks and 1 month after intervention ]Using the Visual Analog Scale (VAS). Each item is scored 0-10 (0= no pain; 10= the major pain that the patient can imagine) yielding a total between 0 and 10.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- People diagnosed with Parkinson disease in mild or moderate degree.
- Age between 50-80 years old.
- People who can answer the questionnaires without held.
- People who commit to attend the treatment assigned in the study.
- People with tremor that limit his/her functionality or cause discomfort.
- People who is not treated the upper limb
Exclusion Criteria:
- People with mental disease.
- People who do not sign the informed consent.
- People who present comorbidities that can affect the final result of the study.
- People whose medication is modified through the study.
- People who take medication whose secundary effect is the tremor appearance.
- People who is participating in other research studies.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04303338
Spain | |
Physiotherapy clinic | |
Madrid, Spain |
Study Director: | Alexander Achalandabaso, PhD | University of Jaen |
Responsible Party: | Alexander Achalandabaso, Principal Investigator, University of Jaén |
ClinicalTrials.gov Identifier: | NCT04303338 |
Other Study ID Numbers: |
CEIM/HU/2019/45 |
First Posted: | March 11, 2020 Key Record Dates |
Last Update Posted: | October 23, 2020 |
Last Verified: | October 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Parkinson disease Essential tremor Neuromuscular Therapy |
Massage Manual Therapy Neurodynamic |
Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Movement Disorders Neurodegenerative Diseases |